Changes in Alcohol Use after Metabolic and Bariatric Surgery: Predictors and Mechanisms

Valentina Ivezaj, Stephen C Benoit, Jon Davis, Scott Engel, Celia Lloret-Linares, James E Mitchell, M Yanina Pepino, Ann M Rogers, Kristine Steffen, Stephanie Sogg, Valentina Ivezaj, Stephen C Benoit, Jon Davis, Scott Engel, Celia Lloret-Linares, James E Mitchell, M Yanina Pepino, Ann M Rogers, Kristine Steffen, Stephanie Sogg

Abstract

Purpose of review: This review synthesized the literature on predictors and mechanisms of post-bariatric alcohol problems, in order to guide future research on prevention and treatment targets.

Recent findings: Consistent evidence suggests an elevated risk of developing problems with alcohol following bariatric surgery. While there is a paucity of empirical data on predictors of problematic alcohol use after bariatric surgery, being male, a younger age, smoking, regular alcohol consumption, pre-surgical alcohol use disorder, and a lower sense of belonging have predicted alcohol misuse post-operatively. This review synthesizes potential mechanisms including specific bariatric surgical procedures, peptides and reinforcement/reward pathways, pharmacokinetics, and genetic influences. Finally, potential misperceptions regarding mechanisms are explored. Certain bariatric procedures elevate the risk of alcohol misuse post-operatively. Future research should serve to elucidate the complexities of reward signaling, genetically mediated mechanisms, and pharmacokinetics in relation to alcohol use across gender and developmental period by surgery type.

Keywords: Alcohol; Alcohol use disorder; Bariatric surgery; Obesity; Roux-en-Y gastric bypass; Sleeve gastrectomy.

Figures

Figure 1.
Figure 1.
Preliminary model of potential mechanisms underlying AUD risk after MBS

References

    1. King W, Chen, Mitchell JE, Kalarchian MA, Steffen KJ, Engel SG, Courcoulas A, Pories Walter J., and Yanovski SZ 2012. ‘Prevalence of alcohol use disorders before and after bariatric surgery’, JAMA, 307: 2516–25.
    1. King WC, Chen JY, Courcoulas AP, Dakin GF, Engel SG, Flum DR, Hinojosa MW, Kalarchian MA, Mattar SG, Mitchell JE, Pomp A, Pories WJ, Steffen KJ, White GE, Wolfe BM, and Yanovski SZ. 2017. ‘Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study’, Surg Obes Relat Dis, 13: 1392–402.

      Examined rates and predictors of alcohol use up to seven yeras following bariatric surgery.

    1. ∙Spadola Christine E., Wagner Eric F., Dillon Frank R., Trepka Mary Jo, De La Cruz-Munoz Nestor, and Messiah Sarah E. 2015. ‘Alcohol and Drug Use Among Postoperative Bariatric Patients: A Systematic Review of the Emerging Research and Its Implications’, Alcohol Clin Exp Res, 39: 1582–601.

      Provides a systematic review of the rates of alcohol and drug use following bariatric surgery.

    1. Saules KK, Wiedemann Ashley A, Ivezaj V, Hopper JA, Foster-Hartsfield, and Schwarz D 2010. ‘Bariatric surgery history among substance abuse treatment patients: prevalence and associated features’, Surg Obes Relat Dis, 6: 615–21.
    1. Cuellar-Barboza AB, Frye MA, Grothe K, Prieto ML, Schneekloth TD, Loukianova LL, Hall-Flavin DK, Clark MM, Karpyak VM, Miller JD, and Abulseoud OA. 2015. ‘Change in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgery’, Journal of Psychosomatic Research, 78: 199–204.
    1. Fogger SA, and McGuinness TM. 2012. ‘The relationship between addictions and bariatric surgery for nurses in recovery’, Perspect Psychiatr Care, 48: 10–5.
    1. Wiedemann AA, Saules KK, and Ivezaj V. 2013. ‘Emergence of New Onset substance use disorders among post-weight loss surgery patients’, Clin Obes, 3: 194–201.
    1. Ertelt TW, Mitchell JE, Lancaster K, Crosby RD, Steffen KJ, and Marino JM. 2008. ‘Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set’, Surg Obes Relat Dis, 4: 647–50.
    1. Ibrahim N, Alameddine M, Brennan J, Sessine M, Holliday C, and Ghaferi AA New onset Alcohol use disorder after bariatric surgery. Surg Endoscopy, In Press. doi: 10.1007/s00464-018-6545-x
    1. Mitchell JE, Lancaster KL, Burgard MA, Howell LM, Krahn DD, Crosby RD, Wonderlich SA, and Gosnell BA. 2001. ‘Long-term follow-up of patients’ status after gastric bypass’, Obesity Surgery, 11: 464–68.
    1. ∙Spadola CE, Wagner EF, Accornero VH, Vidot DC, de la Cruz-Munoz N, and Messiah SE 2017. ‘Alcohol use patterns and alcohol use disorders among young adult, ethnically diverse bariatric surgery patients’, Substance Abuse, 38: 82–87.

      Examined alcohol use patterns and alcohol use disorder among a diverse group of young adults.

    1. Suzuki Joji, Haimovici Florina, and Chang Grace. 2012. ‘Alcohol Use Disorders After Bariatric Surgery’, Obes Surg, 22: 201–07.
    1. Svensson PA, Anveden A, Romeo S, Peltonen M, Ahlin S, Burza MA, Carlsson B, Jacobson P, Lindroos AK, Lonroth H, Maglio C, Naslund I, Sjoholm K, Wedel H, Soderpalm B, Sjostrom L, and Carlsson LM. 2013. ‘Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study’, Obesity (Silver Spring), 21: 2444–51.
    1. Wee Christina C., Mukamal Kenneth J., Huskey Karen W., Davis Roger B., Colten Mary Ellen, Bolcic-Jankovic Dragana, Apovian Caroline M., Jones Daniel B., and Blackburn George L.. 2014. ‘High-risk alcohol use after weight loss surgery’, Surg Obes Relat Dis, 10: 508–13.
    1. Ostlund MP, Backman O, Marsk R, Stockeld D, Lagergren J, Rasmussen F, and Naslund E.. 2013. ‘Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery’, JAMA Surg, 148: 374–7.
    1. Nolen-Hoeksema S. 2004. ‘Gender differences in risk factors and consequences for alcohol use and problems’, Clinical Psychology Review, 24: 981–1010.
    1. Hasin DS, Stinson FS, Ogburn E, and Grant BF. 2007. ‘Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States - Results from the National Epidemiologic Survey on Alcohol and Related Conditions’, Archives of General Psychiatry, 64: 830–42.
    1. Conner KR, Pinquart M, and Gamble SA. 2009. ‘Meta-analysis of depression and substance use among individuals with alcohol use disorders’, Journal of Substance Abuse Treatment, 37: 127–37.
    1. Keyes KM, Hasin DS. Socioeconomic status and problem alcohol use: the positive relationship between income and the DSM-IV alcohol abuse diagnosis. Addiction. 2008;103:1120–30.
    1. ∙∙Zeller MH, Washington GA, Mitchell JE, Sarwer DB, Reiter-Purtill J, Jenkins TM, Courcoulas AP, Peugh JL, Michalsky MP, Inge TH, TEEN-LABS Consortium, and TeenView Study Grp. 2017. ‘Alcohol use risk in adolescents 2 years after bariatric surgery’, Surgery for Obesity and Related Diseases, 13: 85–94.

      Compared group differences in alcohol use between bariatric surgery and a matched control group of adolescents.

    1. Ochner CN, Gibson C, Carnell S, Dambkowski C, Geliebter A. 2010. ‘The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity’, Physiol Behav, 100: 549–59.
    1. Miras AD, le Roux CW 2013. ‘Mechanisms underlying weight loss after bariatric surgery’, Nature Reviews Gastroenterology & Hepatology, 10: 575–84.
    1. Dimitriadis GK, Randeva MS, and Miras AD. 2017. ‘Potential Hormone Mechanisms of Bariatric Surgery’, Curr Obes Rep, 6: 253–65.
    1. Sandoval D. 2011. ‘Bariatric surgeries: beyond restriction and malabsorption’, Int J Obes (Lond), 35 Suppl 3: S45–9.
    1. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, and Richart C.. 2004. ‘Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity’, Obes Res, 12: 962–71.
    1. Ochner CN, Gibson C, Shanik M, Goel V, and Geliebter A.. 2011. ‘Changes in neurohormonal gut peptides following bariatric surgery’, Int J Obes (Lond), 35: 153–66.
    1. Ozsoy Z, and Demir E.. 2018. ‘Which Bariatric Procedure Is the Most Popular in the World? A Bibliometric Comparison’, Obesity Surgery, 28: 2339–52.
    1. Akkary E, Duffy A, Bell R. 2008. ‘Deciphering the Sleeve: Technique, Indications, Efficacy, and Safety of Sleeve Gastrectomy’. Obes Surg, 18: 1323–9.
    1. Davis JF, Tracy AL, Schurdak JD, Magrisso IJ, Grayson BE, Seeley RJ, and Benoit SC. 2013. ‘Roux en Y Gastric Bypass Increases Ethanol Intake in the Rat’, Obesity Surgery, 23: 920–30.
    1. Hajnal A, Zharikov A, Polston JE, Fields MR, Tomasko J, Rogers AM, Volkow ND, and Thanos PK. 2012. ‘Alcohol Reward Is Increased after Roux-en-Y Gastric Bypass in Dietary Obese Rats with Differential Effects following Ghrelin Antagonism’, Plos One, 7.
    1. Polston JE, Pritchett CE, Tomasko JM, Rogers AM, Leggio L, Thanos PK, Volkow ND, and Hajnal A.. 2013. ‘Roux-en-Y Gastric Bypass Increases Intravenous Ethanol Self-Administration in Dietary Obese Rats’, Plos One, 8.
    1. ∙∙Sirohi S, Richardson BD, Lugo JM, Rossi DJ, and Davis JF 2017. ‘Impact of Roux-en-Y gastric bypass surgery on appetite, alcohol intake behaviors, and midbrain ghrelin signaling in the rat’, Obesity (Silver Spring), 25: 1228–36.

      Discusses the importance of ghrelin signaling on appetite and alcohol using preclinical data.

    1. Thanos PK, Subrize M, Delis F, Cooney RN, Culnan D, Sun M, Wang GJ, Volkow ND, and Hajnal A.. 2012. ‘Gastric bypass increases ethanol and water consumption in diet-induced obese rats’, Obes Surg, 22: 1884–92.
    1. Jerlhag E, Ivanoff L, Vater A, and Engel JA. 2014. ‘Peripherally Circulating Ghrelin Does NotMediate Alcohol- Induced Reward and Alcohol Intake in Rodents’, Alcoholism-Clinical and Experimental Research, 38: 959–68.
    1. Holst B, and Schwartz TW. 2004. ‘Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation’, Trends in Pharmacological Sciences, 25: 113–17.
    1. Verebey K, and Gold MS. 1988. ‘From Coca Leaves to Crack - the Effects of Dose and Routes of Administration in Abuse Liability’, Psychiatric Annals, 18: 513–20.
    1. Hatsukami DK, and Fischman MW. 1996. ‘Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?’, JAMA, 276: 1580–8.
    1. Klockhoff H, Naslund I, and Jones AW. 2002. ‘Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery’, Br J Clin Pharmacol, 54: 587–91.
    1. Hagedorn JC, Encarnacion B, Brat GA, and Morton JM 2007. ‘Does gastric bypass alter alcohol metabolism?’, Surg Obes Relat Dis, 3: 543–48.
    1. Woodard Gavitt A., Downey John, Hernandez-Boussard Tina, and Morton John M. 2011. ‘Impaired Alcohol Metabolism after Gastric Bypass Surgery: A Case-Crossover Trial’, J Am Coll Surg, 212: 209–14.
    1. Steffen Kristine J., Engel Scott G., Pollert Garrett A., Li Cao, and Mitchell James E.. 2013. ‘Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass’, Surg Obes Relat Dis, 9: 470–73.
    1. Harger RN, Forney RB, and Baker RS. 1956. ‘Estimation of the Level of Blood-Alcohol from Analysis of Breath .2. Use of Rebreathed Air’, Quarterly Journal of Studies on Alcohol, 17: 1–18.
    1. Jones AW, Lindberg L, and Olsson SG. 2004. ‘Magnitude and time-course of arterio-venous differences in blood-alcohol concentration in healthy men’, Clinical Pharmacokinetics, 43: 1157–66.
    1. ∙∙Pepino MY, Okunade AL, Eagon JC, Bartholow BD, Bucholz K, and Klein S. 2015. ‘Effect of Roux-en-Y Gastric Bypass Surgery: Converting 2 Alcoholic Drinks to 4’, JAMA Surg.

      Examined the subjective effects of ingested alcohol using arterialized blood samples among individuals who underwent RYGB.

    1. Changchien EM, Woodard GA, Hernandez-Boussard T, and Morton JM. 2012. ‘Normal alcohol metabolism after gastric banding and sleeve gastrectomy: a case-cross-over trial’, J Am Coll Surg, 215: 475–9.
    1. Gallo AS, Berducci MA, Nijhawan S, Nino DF, Broderick RC, Harnsberger CR, Lazar S, Echon C, Fuchs HF, Alvarez F, Sandler BJ, Jacobsen G, and Horgan S.. 2015. ‘Alcohol metabolism is not affected by sleeve gastrectomy’, Surg Endosc, 29: 1088–93.
    1. Maluenda Fernando, Csendes Attila, Xabier De Aretxabala Jaime Poniachik, Salvo Karen, Delgado Iris, and Rodriguez Patricia. 2010. ‘Alcohol Absorption Modification After a Laparoscopic Sleeve Gastrectomy Due to Obesity’, Obes Surg, 20: 744–48.
    1. ∙∙Acevedo MB, Eagon JC, Bartholow BD, Klein S, Bucholz KK, and Pepino MY 2018. ‘Sleeve gastrectomy surgery: when 2 alcoholic drinks are converted to 4’, Surgery for Obesity and Related Diseases, 14: 277–83.

      Examined pharmacologic and subjective effects of alcohol following SG and RYGB.

    1. Prom-Wormley EC, Ebejer J, Dick DM, and Bowers MS. 2017. ‘The genetic epidemiology of substance use disorder: A review’, Drug and Alcohol Dependence, 180: 241–59.
    1. Winnier DA, Fourcaudot M, Norton L, Abdul-Ghani MA, Hu SL, Farook VS, Coletta DK, Kumar S, Puppala S, Chittoor G, Dyer TD, Arya R, Carless M, Lehman DM, Curran JE, Cromack DT, Tripathy D, Blangero J, Duggirala R, Goring HHH, DeFronzo RA, and Jenkinson CP. 2015. ‘Transcriptomic Identification of ADH1B as a Novel Candidate Gene for Obesity and Insulin Resistance in Human Adipose Tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES)’, Plos One, 10.
    1. Wang GJ, Volkow ND, and Fowler JS. 2002. ‘The role of dopamine in motivation for food in humans: implications for obesity’, Expert Opin Ther Targets, 6: 601–9.
    1. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, and Fowler JS. 2001. ‘Brain dopamine and obesity’, Lancet, 357: 354–7.
    1. Romer AL, Kang MS, Nikolova YS, Gearhardt AN, and Hariri AR. 2019. ‘Dopamine genetic risk is related to food addiction and body mass through reduced reward-related ventral striatum activity’, Appetite, 133: 24–31.
    1. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, Taub M, Montgomery AR, Sheridan PJ, and Cull JG. 1996. ‘Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report’, Pharmacogenetics, 6: 297–305.
    1. Thompson MD, Kenna GA Variation in the serotonin transporter gene and alcoholism : Risk and response to pharmacotherapy. Alcohol Alcohol. 2016. ;51 :164–171.
    1. Need AC, Ahmadi KR, Spector TD, Goldstein DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet. 2006;70:293–303.
    1. Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, and Hesse S.. 2017. ‘Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity’, Translational Psychiatry, 7.
    1. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Felix R, et al. LifeLines Cohort Study, ADIPOGen Consortium, AGEN-BMI Working Grp, CARDIOGRAMplusC4D Consortium, CKDGen Consortium, GLGC, ICBP, MAGIC Investigators, MuTHER Consortium, MIGen Consortium, PAGE Consortium, ReproGen Consortium, GENIE Consortium, and Int Endogene Consortium. 2015. ‘Genetic studies of body mass index yield new insights for obesity biology’, Nature, 518: 197–U401.
    1. Serra-Juhe C, Martos-Moreno GA, de Pieri FB, Flores R, Gonzalez JR, Rodriguez-Santiago B, Argente J, and Perez-Jurado LA. 2017. ‘Novel genes involved in severe early-onset obesity revealed by rare copy number and sequence variants’, Plos Genetics, 13.
    1. Mahna D, Puri S, and Sharma S.. 2018. ‘DNA methylation signatures: Biomarkers of drug and alcohol abuse’, Mutation Research-Reviews in Mutation Research, 777: 19–28.
    1. Palmisano M, and Pandey SC. 2017. ‘Epigenetic mechanisms of alcoholism and stress-related disorders’, Alcohol, 60: 7–18.
    1. Still CD, Wood GC, Chu X, Erdman R, Manney CH, Benotti PN, Petrick AT, Strodel WE, Mirshahi UL, Mirshahi T, Carey DJ, and Gerhard GS. 2011. ‘High Allelic Burden of Four Obesity SNPs Is Associated With Poorer Weight Loss Outcomes Following Gastric Bypass Surgery’, Obesity, 19: 1676–83.
    1. ∙Morcillo S, Macias-Gonzalez M, and Tinahones FJ 2017. ‘The Effect of Metabolic and Bariatric Surgery on DNA Methylation Patterns’, Current Atherosclerosis Reports, 19.

      Reviews the literature on DNA methylation patterns and metabolic improvement after bariatric surgery.

    1. Nicoletti CF, Cortes-Oliveira C, Pinhel MAS, and Nonino CB. 2017. ‘Bariatric Surgery and Precision Nutrition’, Nutrients, 9.
    1. Day SE, Garcia LA, Coletta RL, Campbell LE, Benjamin TR, De Filippis EA, Madura JA 2nd, Mandarino LJ, Roust LR, and Coletta DK 2017. ‘Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery’, Clin Epigenetics, 9: 96.
    1. Testino G, and Fagoonee S.. 2018. ‘Alcohol Use Disorders and Bariatric Surgery’, Obesity Surgery, 28: 3304–05.
    1. McFadden KM 2010. ‘Cross-Addiction: From Morbid Obesity to Substance Abuse’, Bariatric Nursing and Surgical Patient Care, 5: 145–78.
    1. Ziauddeen H, and Fletcher PC. 2013. ‘Is food addiction a valid and useful concept?’, Obesity Reviews, 14: 19–28.
    1. Ivezaj V, Saules KK, and Schuh LM. 2014. ‘New-onset substance use disorder after gastric bypass surgery: rates and associated characteristics’, Obes Surg, 24: 1975–80.
    1. Lynch A. ‘“When the honeymoon is over, the real work begins:” 2016. Gastric bypass patients’ weight loss trajectories and dietary change experiences’, Soc Sci Med, 151: 241–9.
    1. Ito S, Izumi T, and Arakawa M.. 1999. ‘Gastrectomy is a risk factor for alcoholism’, Internal Medicine, 38: 751–51.
    1. Lundegardh G, Helmick C, Zack M, Adami HO. Mortality among patients with partial gastrectomy for benign ulcer disease. Dig Dis Sci. 1994;39:340–6.
    1. Yokoyama A, Takagi T, Ishii H, Wada N, Maruyama K, Takagi S, and Hayashida M.. 1995. ‘Gastrectomy Enhances Vulnerability to the Development of Alcoholism’, Alcohol, 12: 213–16.
    1. Burgos MG, Cabral PC, Maio R, et al. (2015). ‘Prevalence of alcohol abuse before and after bariatric surgery associated with nutritional and lifestyle factors’. Obes Surg, 25: 1716–1722.

Source: PubMed

3
Abonnieren